Email
Print
1. Engineered T Cells Market - Overview
1.1 Definitions and Scope
2. Engineered T Cells Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Engineered T Cells Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Engineered T Cells Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Engineered T Cells Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Engineered T Cells Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Engineered T Cells Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Engineered T Cells Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Chimeric Antigen Receptor Modified T Cell
8.3.2 T Cell Receptor Modified T Cell
8.3.3 Tumor Infiltrating Lymphocyte
9. Engineered T Cells Market - By End User (Market Size -$Million / $Billion)
9.1 Hospital
9.2 Cancer Research Center
9.3 Clinic
10. Engineered T Cells - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Lung Cancer
10.3.2 Breast Cancer
10.3.3 Colorectal Cancer
10.3.4 Melanoma
10.3.5 Leukemia
10.3.6 Others Application
11. Engineered T Cells- By Geography (Market Size -$Million / $Billion)
11.1 Engineered T Cells Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Engineered T Cells- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Engineered T Cells- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Engineered T Cells - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Engineered T Cells - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Engineered T Cells Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Engineered T Cells Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Engineered T Cells Market - Key Company List by Country Premium
15. Engineered T Cells Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Autolus Limited
15.3 Bellicum Pharmaceuticals, Inc
15.4 Cell Medica Limited
15.5 Eli Lilly And Company
15.6 Gilead Sciences, Inc
15.7 Juno Therapeutics, Inc
15.8 Novartis Ag
15.9 Oxford Biomedica Plc
15.10 Pfizer Inc
15.11 Precision Bioscience Inc
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Engineered T Cells Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Engineered T Cells Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Engineered T Cells Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Engineered T Cells Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Engineered T Cells Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Engineered T Cells Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Engineered T Cells Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Engineered T Cells Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Chimeric Antigen Receptor Modified T Cell
8.3.2 T Cell Receptor Modified T Cell
8.3.3 Tumor Infiltrating Lymphocyte
9. Engineered T Cells Market - By End User (Market Size -$Million / $Billion)
9.1 Hospital
9.2 Cancer Research Center
9.3 Clinic
10. Engineered T Cells - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Lung Cancer
10.3.2 Breast Cancer
10.3.3 Colorectal Cancer
10.3.4 Melanoma
10.3.5 Leukemia
10.3.6 Others Application
11. Engineered T Cells- By Geography (Market Size -$Million / $Billion)
11.1 Engineered T Cells Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Engineered T Cells- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Engineered T Cells- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Engineered T Cells - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Engineered T Cells - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Engineered T Cells Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Engineered T Cells Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Engineered T Cells Market - Key Company List by Country Premium
15. Engineered T Cells Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Autolus Limited
15.3 Bellicum Pharmaceuticals, Inc
15.4 Cell Medica Limited
15.5 Eli Lilly And Company
15.6 Gilead Sciences, Inc
15.7 Juno Therapeutics, Inc
15.8 Novartis Ag
15.9 Oxford Biomedica Plc
15.10 Pfizer Inc
15.11 Precision Bioscience Inc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Engineered T Cells Market - Appendix16.1 Abbreviations
16.2 Sources
17. Engineered T Cells Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Engineered T Cell Market, By Type Market 2023-2030 ($M)1.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Global Industry Research
1.1.1 And Opportunity Market 2023-2030 ($M)
1.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Global Industry Research
1.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Global Industry Research
2.Global Engineered T Cell Market, By End User Market 2023-2030 ($M)
2.1 Hospital Market 2023-2030 ($M) - Global Industry Research
2.2 Cancer Research Center Market 2023-2030 ($M) - Global Industry Research
2.3 Clinic Market 2023-2030 ($M) - Global Industry Research
3.Global Engineered T Cell Market, By Type Market 2023-2030 (Volume/Units)
3.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 And Opportunity Market 2023-2030 (Volume/Units)
3.2 T Cell Receptor Modified T Cell Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Tumor Infiltrating Lymphocyte Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Engineered T Cell Market, By End User Market 2023-2030 (Volume/Units)
4.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Cancer Research Center Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Engineered T Cell Market, By Type Market 2023-2030 ($M)
5.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
5.1.1 And Opportunity Market 2023-2030 ($M)
5.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
5.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Regional Industry Research
6.North America Engineered T Cell Market, By End User Market 2023-2030 ($M)
6.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
6.2 Cancer Research Center Market 2023-2030 ($M) - Regional Industry Research
6.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
7.South America Engineered T Cell Market, By Type Market 2023-2030 ($M)
7.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
7.1.1 And Opportunity Market 2023-2030 ($M)
7.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
7.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Regional Industry Research
8.South America Engineered T Cell Market, By End User Market 2023-2030 ($M)
8.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
8.2 Cancer Research Center Market 2023-2030 ($M) - Regional Industry Research
8.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
9.Europe Engineered T Cell Market, By Type Market 2023-2030 ($M)
9.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
9.1.1 And Opportunity Market 2023-2030 ($M)
9.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
9.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Regional Industry Research
10.Europe Engineered T Cell Market, By End User Market 2023-2030 ($M)
10.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
10.2 Cancer Research Center Market 2023-2030 ($M) - Regional Industry Research
10.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
11.APAC Engineered T Cell Market, By Type Market 2023-2030 ($M)
11.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
11.1.1 And Opportunity Market 2023-2030 ($M)
11.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
11.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Regional Industry Research
12.APAC Engineered T Cell Market, By End User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Cancer Research Center Market 2023-2030 ($M) - Regional Industry Research
12.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
13.MENA Engineered T Cell Market, By Type Market 2023-2030 ($M)
13.1 Chimeric Antigen Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
13.1.1 And Opportunity Market 2023-2030 ($M)
13.2 T Cell Receptor Modified T Cell Market 2023-2030 ($M) - Regional Industry Research
13.3 Tumor Infiltrating Lymphocyte Market 2023-2030 ($M) - Regional Industry Research
14.MENA Engineered T Cell Market, By End User Market 2023-2030 ($M)
14.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
14.2 Cancer Research Center Market 2023-2030 ($M) - Regional Industry Research
14.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Engineered T Cells Market Revenue, 2023-2030 ($M)2.Canada Engineered T Cells Market Revenue, 2023-2030 ($M)
3.Mexico Engineered T Cells Market Revenue, 2023-2030 ($M)
4.Brazil Engineered T Cells Market Revenue, 2023-2030 ($M)
5.Argentina Engineered T Cells Market Revenue, 2023-2030 ($M)
6.Peru Engineered T Cells Market Revenue, 2023-2030 ($M)
7.Colombia Engineered T Cells Market Revenue, 2023-2030 ($M)
8.Chile Engineered T Cells Market Revenue, 2023-2030 ($M)
9.Rest of South America Engineered T Cells Market Revenue, 2023-2030 ($M)
10.UK Engineered T Cells Market Revenue, 2023-2030 ($M)
11.Germany Engineered T Cells Market Revenue, 2023-2030 ($M)
12.France Engineered T Cells Market Revenue, 2023-2030 ($M)
13.Italy Engineered T Cells Market Revenue, 2023-2030 ($M)
14.Spain Engineered T Cells Market Revenue, 2023-2030 ($M)
15.Rest of Europe Engineered T Cells Market Revenue, 2023-2030 ($M)
16.China Engineered T Cells Market Revenue, 2023-2030 ($M)
17.India Engineered T Cells Market Revenue, 2023-2030 ($M)
18.Japan Engineered T Cells Market Revenue, 2023-2030 ($M)
19.South Korea Engineered T Cells Market Revenue, 2023-2030 ($M)
20.South Africa Engineered T Cells Market Revenue, 2023-2030 ($M)
21.North America Engineered T Cells By Application
22.South America Engineered T Cells By Application
23.Europe Engineered T Cells By Application
24.APAC Engineered T Cells By Application
25.MENA Engineered T Cells By Application
26.Autolus Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bellicum Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Cell Medica Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Gilead Sciences, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Juno Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Oxford Biomedica Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Precision Bioscience Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)